Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
'No reason to slow down anything here': CureVac plans to march on with Covid-19 vaccine after pivotal failure
4 years ago
Biden invests $3B into antiviral development for Covid-19
4 years ago
Covid-19 manufacturing roundup: As the US government bags another 100M doses of Moderna shot, the biotech is chipping in on UAE rollout
4 years ago
Manufacturing
Covid-19 roundup: Pfizer says Xeljanz reduced death and lung failure in hospitalized Covid-19 patients; US halts distribution of Eli Lilly’s mAb combo to Rhode Island due to variants
4 years ago
In a first, Regeneron's antibody cocktail reduces deaths for a subgroup of hospitalized Covid-19 patients
4 years ago
R&D
Covid-19 roundup: Real world data suggest AstraZeneca vaccine effective against Delta, Alpha variants; Novavax hails positive study on coronavirus, flu shots combo
4 years ago
AstraZeneca's Covid-19 antibody cocktail misses the mark in preventing symptoms post-exposure
4 years ago
R&D
Covid-19 roundup: Germany puts J&J on the hotseat for vaccine backorder; Top EMA official suggests forgoing AstraZeneca shot
4 years ago
75M vaccine doses wasted: FDA spells out Emergent facility deficiencies at length in new memo
4 years ago
FDA+
Long-awaited Novavax PhIII results show 90.3% overall efficacy, with 100% effectiveness against moderate and severe Covid-19
4 years ago
As it expands its footprint, Moderna reaches deal to commercialize Covid-19 vaccine doses in Middle East
4 years ago
Manufacturing
FDA authorizes about 10M J&J vaccine doses, trashes 60M more from troubled Emergent plant
4 years ago
FDA+
Covid-19 roundup: 60 million J&J doses from Emergent to be tossed; EMA updates AstraZeneca vaccine warnings
4 years ago
Covid-19 manufacturing roundup: BioNTech announces plans to produce mRNA vaccines in Africa; AstraZeneca deliveries from Thailand delayed
4 years ago
Manufacturing
Covid-19 roundup: Moderna has filed for vaccine use in children; Claiming leadership to combat Covid-19, US pledges to donate 500M doses of Pfizer/BioNTech vaccines through COVAX
4 years ago
US to shell out $1.2B for supplies of Merck's potential Covid-19 antiviral
4 years ago
R&D
Covid-19 roundup: Pharmacist who tampered with Moderna vaccines sentenced to 3 years in jail; FDA says J&J shelf life may be extended
4 years ago
Covid-19 vaccines for kids: FDA spells out questions on immunobridging, safety followup ahead of adcomm
4 years ago
FDA+
Covid-19 roundup: CureVac vaccine now not expected before August — report; A Covid-19 vaccine trial in Africa is ready to test patients with HIV, but there aren't any vaccines available for it
4 years ago
Covid-19 roundup: Moderna gets the OK to use vaccine in children ages 12-17; 23andMe finds genetic link to loss of taste and smell
4 years ago
Elizabeth Warren wants Gilead CEO Daniel O'Day in the hot seat to talk drug pricing and competitiveness
4 years ago
People
Covid-19 roundup: EU calls on WTO members to expand vaccine and treatment manufacturing; US removes DPA priority ratings for AstraZeneca, J&J and Sanofi
4 years ago
Regeneron continues reign atop the Covid treatment field with expanded EUA for lower dose subcutaneous version of mAb cocktail
4 years ago
FDA+
As the mRNA push continues, Samsung will expand its drug substance manufacturing at South Korean hub
4 years ago
Manufacturing
First page
Previous page
25
26
27
28
29
30
31
Next page
Last page